Navigation Links
Influenza virus strains show increasing drug resistance and ability to spread
Date:12/7/2010

Two new studies raise public health concerns about increasing antiviral resistance among certain influenza viruses, their ability to spread, and a lack of alternative antiviral treatment options. The findings are published in the January 1 issue of The Journal of Infectious Diseases. (Please see below for links to these articles online.)

Influenza viruses are treated with two classes of drugs: M2 blockers (adamantanes) and neuraminidase inhibitors (NAIs), including oseltamivir and zanamivir. While the spread of influenza strains with resistance to one class of drugs has been well documented in recent years, a new report from Larisa Gubareva, MD, PhD and colleagues at the Centers for Disease Control and Prevention (CDC) and at health agencies in West Virginia, Texas, and Canada, confirms that dual resistance can emerge in several ways and has been on the rise during the past three years.

The study analyzed 28 seasonal H1N1 viruses with dual resistance from 2008 to 2010 from five countries, revealing that additional antiviral resistance could rapidly develop in a previously single-resistant strain as a result of mutation, drug response, or gene exchange with another virus.

Although dual resistant viruses are still rare, the investigators noted an increase in the number of tested viruses with this resistance, from 0.06 percent (2007-2008) to 1.5 percent (2008-2009) to 28 percent (2009-2010); however, during the 2009-2010 season the number of circulating seasonal H1N1 viruses was low, and only 25 viruses were tested. "Because only two classes of antiviral agents are approved, the detection of viruses with resistance to drugs in both classes is concerning," said Dr. Gubareva. "If circulation of viruses with dual resistance becomes more widespread among any of the predominant circulating influenza A viruses, treatment options will be extremely limited. New antiviral agents and strategies for antiviral therapy are likely to be ne
'/>"/>

Contact: John Heys
jheys@idsociety.org
703-299-0412
Infectious Diseases Society of America
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. H1N1 international symposium to be hosted by Emory-UGA Influenza Center
2. Aggressive response helped Chilean hospital improve H1N1 influenza outcomes
3. Families Fighting Flu Commends the CDCs Advisory Committee on Immunization Practices Recommendation for Universal Influenza Vaccination
4. Preventive behaviors limited household transmission of H1N1 influenza during initial outbreak
5. Influenza in pregnancy -- new Norwegian study
6. Rapid development of drug-resistant 2009 H1N1 influenza reported in 2 cases
7. Building a better flu vaccine: Add second strain of influenza B
8. Study finds that drugs used for treatment of influenza in pregnancy appear to be safe
9. Fear of pandemic influenza clogs EDs even when disease is not present
10. H1N1 influenza hits older children
11. Mount Sinai researchers move closer to a universal influenza vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... March 03, 2015 The first week ... National Sleep Foundation. The event brings recognition to a ... , According to the Centers for Disease ... of one form or another. Too little or unrestful ... of physical illness and depression, and even a higher ...
(Date:3/3/2015)... Mason, OH (PRWEB) March 03, 2015 ... found to better predict antidepressant treatment outcomes for ... care resources, than any of the individual genes ... analysis by investigators from the Mayo Clinic and ... Journal i. , The proprietary technology of ...
(Date:3/3/2015)... March 03, 2015 The ... estimated to grow from $1,224.6 million to ... between 2014 and 2019. , Browse through ... network market for an analysis of industry ... various tables and figures., http://www.micromarketmonitor.com/market/north-america-application-delivery-network-adn-7381582251.html ...
(Date:3/3/2015)... (March 3, 2015) (PRWEB) March 03, 2015 ... (FCV), an innovator in the travel industry for the ... trailblazing expansion plan. To fulfill his vision for the ... of 400 fun, exciting and well-compensated positions as travel ... a news sales center planned for the Boynton Beach, ...
(Date:3/3/2015)... 03, 2015 March 3, 2015, My Positive ... episode. The episode was a unique one, not just because ... because it featured two men who were both faced with ... the beginning of the episode, Deierlein said to Collins, “I ... radio show, but I’m very excited that you could join ...
Breaking Medicine News(10 mins):Health News:Medicationdiscountcard.com recognizes sleep awareness week with discounts on sleep meds including Ambien, Lunesta, and Sonata 2Health News:Medicationdiscountcard.com recognizes sleep awareness week with discounts on sleep meds including Ambien, Lunesta, and Sonata 3Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 2Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 3Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 4Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 5Health News:GeneSight Multi-Gene Combinatorial Pharmacogenomic (CPGx™) Test is More Predictive of Antidepressant Response than Single Gene Tests 6Health News:The North American Application Delivery Network Market is Estimated to Reach $1,694.6 Million in 2019- A Report By MicroMarket Monitor 2Health News:The North American Application Delivery Network Market is Estimated to Reach $1,694.6 Million in 2019- A Report By MicroMarket Monitor 3Health News:First Class Vacations, Inc. Expansion Plan Creates 400 Jobs In South Florida 2Health News:First Class Vacations, Inc. Expansion Plan Creates 400 Jobs In South Florida 3Health News:My Positive Perspective Releases Episode #200 With Car Accident and Coma Survivor Nick Collins 2
... of Soy Trial (BEST), a Baltimore-based randomized controlled study ... pertaining to cholesterol reduction, metabolic syndrome, and recruitment for ... by Johns Hopkins University School of Nursing (JHUSON) researcher ... its findings this month in Menopause and Ethnicity and ...
... a condition that causes clogging and narrowing of the ... their walls. //Over a period of time, the plaque ... of arteries usually happens in adults. ,But, ... McMaster University in Hamilton, Ontario, have presented a report ...
... that lead to dehydration can signal a future attack for ... American// College of Rheumatology Annual Scientific Meeting in Washington DC. ... causes severe pain and swelling of the joints. The attacks, ... few days, most often the big toe, can also generate ...
... A new study published by CANCER (a peer-reviewed ... than 47% of the breast cancer patients met ... a psychiatric disorder, including major depression and post-traumatic ... virtually all of the women admitted have been ...
... Day is an opportune time to evaluate the support ... world coping with a galloping disease. Taking// cognizance of ... Care for Everyone, especially the disadvantaged and the vulnerable’ ... ,The global initiative in diabetes management seeks ...
... HIV infection among injection drug users in Taiwan has led ... year according to a// health official. ,Last ... only a 10th of the total budget for HIV programs, ... at Taiwan's Center for Disease Control. However, next year this ...
Cached Medicine News:Health News:Soy Protein Study Generates New Findings 2Health News:It's the Heat and the Humidity: How Each Worsens Gout Symptoms 2Health News:Breast Cancer Patients Suffer From Psychological Problems 2Health News:The Holy Grail of Diabetes Management 2Health News:The Holy Grail of Diabetes Management 3Health News:Surge of HIV Cases in Taiwan Prompts Doubling in Expenditure for HIV Prevention 2
(Date:3/3/2015)... March 3, 2015 Based on its ... Frost & Sullivan recognizes Neopeutics, Inc. with the ... Technology Leadership. Neopeutics has demonstrated a remarkable ability ... and easily adaptable set of drug discovery instruments. ... as failing compounds in the early stages of ...
(Date:3/3/2015)... 3, 2015 /CNW/ - ChipCare Corporation, a University of ... for HIV and other infectious and non-communicable diseases ... to bring its first-generation product to market while ... (Photo: http://photos.prnewswire.com/prnh/20150303/179107 ) ... simple, accurate and affordable diagnostic tests makes it ...
(Date:3/3/2015)... 2015  Delcath Systems, Inc. (NASDAQ: ... company focused on oncology with an emphasis on ... announces that the results from its Phase 3 ... been submitted for publication in a leading peer-reviewed ... for Injection for use with the Delcath Hepatic ...
Breaking Medicine Technology:Frost & Sullivan Applauds Neopeutics' Commitment to Accelerating the Delivery of New Nature-Based Pharmaceuticals and Therapeutics 2Frost & Sullivan Applauds Neopeutics' Commitment to Accelerating the Delivery of New Nature-Based Pharmaceuticals and Therapeutics 3Frost & Sullivan Applauds Neopeutics' Commitment to Accelerating the Delivery of New Nature-Based Pharmaceuticals and Therapeutics 4Frost & Sullivan Applauds Neopeutics' Commitment to Accelerating the Delivery of New Nature-Based Pharmaceuticals and Therapeutics 5ChipCare Closes Oversubscribed $5 Million Series A Financing 2ChipCare Closes Oversubscribed $5 Million Series A Financing 3Delcath Announces Submission Of Phase 3 Trial Results For Publication In A Leading Peer-Reviewed Medical Journal 2Delcath Announces Submission Of Phase 3 Trial Results For Publication In A Leading Peer-Reviewed Medical Journal 3Delcath Announces Submission Of Phase 3 Trial Results For Publication In A Leading Peer-Reviewed Medical Journal 4
... Hospital and public health laboratories across the country are ... tests since the launch of Abbott,s ARCHITECT ® ... 2010. Researchers reported finding early stage infections in places ... S.D., where HIV infections are believed to be low. ...
... /PRNewswire-Asia/ -- Simcere Pharmaceutical Group (NYSE: SCR ... manufacturing, and marketing of branded generic and proprietary pharmaceuticals ... unaudited financial results for the second quarter ended June ... market opens in the United States. Simcere,s management will ...
Cached Medicine Technology:Abbott's HIV Combo Test Detects Infections Earlier, Provides Valuable Information to Help Prevent Further HIV Transmission and May Save Treatment Costs 2Abbott's HIV Combo Test Detects Infections Earlier, Provides Valuable Information to Help Prevent Further HIV Transmission and May Save Treatment Costs 3Abbott's HIV Combo Test Detects Infections Earlier, Provides Valuable Information to Help Prevent Further HIV Transmission and May Save Treatment Costs 4Abbott's HIV Combo Test Detects Infections Earlier, Provides Valuable Information to Help Prevent Further HIV Transmission and May Save Treatment Costs 5Simcere Pharmaceutical Group to Announce Second Quarter 2011 Financial Results on Tuesday, August 9, 2011 2
Sealing Mat for 96-well PCR Plate, Natural...
... unit, these new pads may be used in applications ... may be sealed with the same pad. The Moto ... sticking to the block and lid, and Microseal P+ ... means you can use as little as 50% of ...
Microseal 'M' mats, seals 96-well plates, reusable, pkg of 10...
An alternative sealing method for samples that are stored in 96-well plates after PCR. The mat is fully autoclavable and can be reused up to 50 times....
Medicine Products: